LearnGlossaryMarketStocksSuperinvestorsSign in

AKAN

Akanda Corp.

Healthcare · $99K market cap

Verdict

We can't put a fair value on AKAN right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth—?
Equity per share growth—?
Sales growth-31.7% a year✗
Free cash flow growth—?
Return on invested capital-65.0%✗

Follow AKAN

Track it on your watchlist and see the full analysis. Free.

Create a free account

About Akanda Corp.

Akanda Corp., operating through its various subsidiary entities, focuses on the cultivation, production, and distribution of cannabis products. The company's operations span the United Kingdom, Lesotho, and other global regions, with a specific aim to provide cannabis-derived items for medical and wellness purposes. Formed in 2021, Akanda Corp. is based out of its main office in New Romney, United Kingdom.

Drug Manufacturers - Specialty & Generic

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works